Agreed. I think providing a customized debt solution with a customer-centric approach and a seamless experience should remain their key focus.
I haven't heard any recent update reading their JV with Cor Cordis and/or Arrow Business Consultants in awhile. Has anyone got any insights as to whether they are still in collaboration? Or, did they just decided to part ways? I think it would be a good opportunity for the management team to update the market about this in the upcoming report, even if things didn't work out.
From memory, I think their intention is to replicate their HK debt solution business model and expand their operations in Australia and Singapore. I'm looking forward to see how Chapter Two has performed over the last 12 month and anxiously waiting for their debt management services license to be approved
- Forums
- ASX - By Stock
- Gaining interest in 2022
Agreed. I think providing a customized debt solution with a...
Featured News
Add CI1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.685M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CI1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online